U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H24N4O3S
Molecular Weight 316.42
Optical Activity ( + )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIMOLOL, (R)-

SMILES

CC(C)(C)NC[C@@H](O)COC1=NSN=C1N2CCOCC2

InChI

InChIKey=BLJRIMJGRPQVNF-SNVBAGLBSA-N
InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/8286 | https://www.ncbi.nlm.nih.gov/pubmed/2896241

(R)-Timolol is the (R)-enantiomer of non-selective Beta antagonist Timolol. (R)-Timolol is a ß-adrenergic blocking agent that binds only to nonspecific sites in the particulate fraction of the heart, lungs, and brain. (R)-Timolol is an antihypertensive agent that increases ocular blood flow and reduces intraocular pressure. (R)-Timolol is one of the impurities in commercial formulation of (S)-Timolol.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
26.9 nM [Kd]
13.8 nM [Kd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Stereospecific binding of timolol, a beta-adrenergic blocking agent.
1976 Jul-Aug
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Rats were treated i.v. with 0.1 mg/kg of (R)-Timolol Rats were treated p.o. with 1-10mg/kg of (R)-Timolol
Route of Administration: Other
In Vitro Use Guide
Rabbit eyes and heart ventricle were from New Zealand albino males, 3 to 6 months old. Chary process villae were separated carefully from any contaminating iris or ciliary body, washed once in 150 mM NaCl and homogenized (10 mg/ml) by hand in an all-glass homogenizer in 6 mM Tris maleate buffer, pH 7.4. Heart tissue was first minced and then homogenized (20-50 mg/ml). Aparticulate (P1) preparation was prepared by diluting the homogenate in 20 volumes of 6 mM Tris maleate buffer, centrifuging at 100,000 x g for 30 min, and resuspending the pellet in the initial volume of buffer used for homogenization. Kinetic constants obtained using the P1 fraction as a source of adenylate cyclase were similar to those obtained using homogenates. Inhibition (by various concentrations of an antagonist) of beta adrenergic receptor-mediated activation of adenylate cyclase activity was used to determine the inhibitory constants. IC50 values were determined utilizing 12 to 16 data points per dose-response curve. For the inhibition curves, various concentrations of antagonist were tested against a fixed concentration of (-)-isoproterenol. Stimulation in the presence of isoproterenol plus antagonist was calculated as the increase over that seen in the presence of antagonist alone.
Name Type Language
TIMOLOL, (R)-
Common Name English
D-TIMOLOL
Common Name English
(+)-TIMOLOL
Common Name English
(R)-(+)-TIMOLOL
Common Name English
2-PROPANOL, 1-((1,1-DIMETHYLETHYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-, (2R)-
Systematic Name English
TIMOLOL ANHYDROUS, (R)-
Common Name English
L-714465
Code English
TIMOLOL, (+)-
Common Name English
TIMOLOL MALEATE IMPURITY A [EP IMPURITY]
Common Name English
(2R)-1-((1,1-DIMETHYLETHYL)AMINO)-3-((4-(MORPHOLIN-4-YL)-1,2,5-THIADIAZOL-3-YL)OXY)PROPAN-2-OL
Systematic Name English
(R)-TIMOLOL
Common Name English
Code System Code Type Description
PUBCHEM
168613
Created by admin on Sat Dec 16 10:07:07 GMT 2023 , Edited by admin on Sat Dec 16 10:07:07 GMT 2023
PRIMARY
CAS
26839-76-9
Created by admin on Sat Dec 16 10:07:07 GMT 2023 , Edited by admin on Sat Dec 16 10:07:07 GMT 2023
PRIMARY
ECHA (EC/EINECS)
248-033-1
Created by admin on Sat Dec 16 10:07:07 GMT 2023 , Edited by admin on Sat Dec 16 10:07:07 GMT 2023
PRIMARY
FDA UNII
2BG20ZUO2E
Created by admin on Sat Dec 16 10:07:07 GMT 2023 , Edited by admin on Sat Dec 16 10:07:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID801318141
Created by admin on Sat Dec 16 10:07:07 GMT 2023 , Edited by admin on Sat Dec 16 10:07:07 GMT 2023
PRIMARY
CHEBI
39466
Created by admin on Sat Dec 16 10:07:07 GMT 2023 , Edited by admin on Sat Dec 16 10:07:07 GMT 2023
PRIMARY